AIM ImmunoTech Inc. Balance Sheet
AIM|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
AIM ImmunoTech Inc. had $6M in total assets with negative shareholders' equity of $10M as of FY2025. Total debt was $4M against $3M in cash, resulting in $1M net debt.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -71.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.0M | $1.7M | $5.4M | $27.1M | $32.1M | $38.5M | $1.5M | $299.0K | $2.4M | $2.4M | $2.1M | $2.2M | $803.0K | $2.2M | $58.1M |
| Accounts Receivable | $7.0K | - | $1.2M | - | - | $34.0K | $44.0K | $235.0K | $24.0K | - | - | - | - | - | - |
| Current Assets | $3.3M | $4.2M | $14.6M | $36.3M | $50.2M | $40.3M | $10.4M | $3.8M | $3.5M | $6.9M | $10.6M | $16.5M | $18.6M | $44.7M | $31.8M |
| PP&E (Net) | $71.0K | $108.0K | $127.0K | $195.0K | $4.0M | $6.5M | $7.1M | $7.8M | $8.6M | $9.5M | $11.2M | $4.6M | $5.1M | $5.3M | $5.3M |
| Total Assets | $5.8M | $8.6M | $19.4M | $40.5M | $57.7M | $64.6M | $20.8M | $13.8M | $14.2M | $18.9M | $22.8M | $29.4M | $31.9M | $57.7M | $43.5M |
| Current Liabilities | $6.2M | $9.5M | $8.7M | $1.4M | $673.0K | $1.1M | $1.1M | $5.3M | $2.7M | $2.4M | $2.4M | $4.4M | $2.5M | $12.6M | $5.1M |
| Total Debt | $4.5M | $2.8M | - | - | - | $2.1M | $2.3M | $2.5M | - | - | - | - | - | - | - |
| Shareholders' Equity | -$9.8M | $10.2M | $38.5M | $56.9M | $61.3M | $61.3M | $13.4M | $5.6M | $15.5M | $15.5M | $20.4M | $25.0M | $29.3M | $44.7M | $58.7M |